Multiples measured against the stock's own five-year history
Around its usual level · 45th percentile, 5-year average 7.5x
#771 of 2977 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 94th percentile, 5-year average 0.7x
#1606 of 5307 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 91st percentile, 5-year average 1.5x
#2436 of 5144 stocks by PS (1 = cheapest)
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.17 | – | 0.72 | 94% (pricier than usual) | #1606 of 5307 (1 = cheapest) |
| PE | 11.55 | 10.18 | 7.50 | 45% (cheaper than usual) | #771 of 2977 (1 = cheapest) |
| PS | 1.94 | 1.83 | 1.46 | 91% (pricier than usual) | #2436 of 5144 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on NMR.